Results 171 to 180 of about 217,588 (352)

Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos   +15 more
wiley   +1 more source

Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report

open access: yesInternational Medical Case Reports Journal, 2018
Naziha Chelaghma, Samson O Oyibo Department of Diabetes & Endocrinology, Peterborough City Hospital, Peterborough, UK Abstract: A 58-year-old man presented with a 3-year history of chronic and intermittent hyperkalemia requiring recurrent ...
Chelaghma N, Oyibo SO
doaj  

BUN‐to‐ALB ratio as an effective predictor of 30 day mortality in ADHF patients in eastern China

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The blood urea nitrogen‐to‐albumin ratio (BAR) is considered a potential indicator for assessing the poor prognosis of heart failure (HF). However, its prognostic value for Chinese patients with acute decompensated HF (ADHF) remains unclear.
Xin Huang   +8 more
wiley   +1 more source

Neurohumoral regulation of blood pressure in rheumatic patients

open access: yesТерапевтический архив, 2009
Aim. To study characteristics of neurohumoral regulation of blood pressure (BP) in patients with systemic diseases of the connective tissue and hemorrhagic vasculitis (HV). Material and methods.
N P Shilkina   +6 more
doaj  

Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence

open access: yesESC Heart Failure, EarlyView.
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta   +10 more
wiley   +1 more source

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy